Egholm Michael
- SEC CIK
- 0001559779
No open-market purchases or sales filed in the past year.
Current role at each company
- LAB Standard Biotools Inc.President & CEOas of Aug 24, 2026
- ISO IsoPlexis CorpDirectoras of Jun 21, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Egholm Michael as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LAB Standard Biotools Inc.
President & CEO3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 22, 2025 (view filing) | May 21 | 1 day | Egholm MichaelPresident & CEO | SSale | −4.72K | $1.03 | −$4.86K | −0.2%2.75M after | |
| May 27, 2025 (view filing) | May 22 | 5 days | Egholm MichaelPresident & CEO | SSale | −5.12K | $1.00 | −$5.12K | −0.2%2.75M after | |
| May 28, 2025 (view filing) | May 23 | 5 days | Egholm MichaelPresident & CEO | SSale | −5.47K | $0.94 | −$5.14K | −0.2%2.74M after |